Takeda Pharmaceutical Company Limited (VIE:TKD)
Austria flag Austria · Delayed Price · Currency is EUR
29.52
+0.10 (0.34%)
Last updated: Feb 4, 2026, 3:30 PM CET

VIE:TKD Ratios and Metrics

Millions EUR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
47,10841,70240,22746,82040,20447,993
Market Cap Growth
16.16%3.67%-14.08%16.45%-16.23%10.12%
Enterprise Value
73,02072,21270,36875,24767,12283,681
Last Close Price
29.4226.5624.1627.0922.35-
PE Ratio
76.7962.5445.5721.3323.5716.57
PS Ratio
1.941.471.541.681.521.95
PB Ratio
1.130.970.901.060.951.20
P/FCF Ratio
8.587.8812.148.085.426.92
P/OCF Ratio
7.296.399.166.924.836.16
EV/Sales Ratio
3.012.552.692.702.543.40
EV/EBITDA Ratio
10.169.4810.048.467.6511.04
EV/EBIT Ratio
22.3720.7622.9917.5415.0925.62
EV/FCF Ratio
13.3013.6521.2312.999.0612.07
Debt / Equity Ratio
0.710.730.750.770.850.98
Debt / EBITDA Ratio
4.093.964.573.794.075.16
Debt / FCF Ratio
5.375.9410.105.814.815.64
Asset Turnover
0.290.310.290.300.270.25
Inventory Turnover
1.161.301.301.361.401.34
Quick Ratio
0.540.440.500.490.731.00
Current Ratio
1.191.011.110.971.211.53
Return on Equity (ROE)
1.50%1.52%2.12%5.27%4.24%7.60%
Return on Assets (ROA)
2.47%2.40%2.15%2.85%2.88%2.06%
Return on Invested Capital (ROIC)
2.76%2.91%4.35%5.15%4.82%4.50%
Return on Capital Employed (ROCE)
4.70%4.80%3.90%5.40%5.40%3.80%
Earnings Yield
1.30%1.60%2.20%4.69%4.24%6.04%
FCF Yield
11.65%12.69%8.24%12.37%18.44%14.44%
Dividend Yield
4.09%4.56%4.77%4.60%5.97%-
Payout Ratio
277.04%280.28%199.34%88.14%123.30%75.36%
Buyback Yield / Dilution
-0.25%-1.58%-0.67%0.46%-0.23%-0.47%
Total Shareholder Return
3.84%2.98%4.10%5.06%5.74%-0.47%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.